Jeff Smith

Chief Executive Officer

Jeff has been the CEO at Alimentiv since October 2016. In May 2018, Jeff led the successful separation of the organization from its sole owner, Western University, to a Health Trust establishing the first social enterprise of its kind in North America.


Jeff has a strong record of leading high-performing global teams that support the growth of global business units. His background in clinical research spans more than 20 years in the pharma and contract research organization (CRO) industries. Prior to his current position, he held senior positions with Alimentiv (formerly Robarts Clinical Trials) including Vice President, Clinical Operations and Director, Business Development. And before joining Alimentiv he was a Senior Director, General Medicine & Vaccines/Infectious Disease with PharmaNet (now Syneos). Jeff trained as a registered nurse, and holds a Bachelor Degree in Health Sciences (nursing).


Jeff’s perspective on building a great company has been shaped from his experience working in a variety of ownership structures including government, private, public, private equity and venture capital. These experiences helped shape his vision for building a 100-year private company that pursues its purpose and putting people first ahead of shareholder returns. In May 2018, he was able to realize this vision with the transition of ownership of Robarts Clinical Trials to a Health Trust.


“When leaders prioritize goodness in themselves and in others, they can create lasting cultures and tremendous value.”

View Profile
Michael Cloutier


Mike Cloutier is an accomplished business leader and consultant with over 39 years in the Life Sciences sector. Over the past 25 years, Mike was General Manager, President and CEO of five major pharmaceutical firms and one Not for Profit organization, the Canadian Diabetes Association (now Diabetes Canada). In 2017, Mike founded a Canadian based global consulting practice, Accelera Canada Ltd. Accelera Canada provides unique and unparalleled “one top support” to US and European based biotech/pharmaceutical companies exploring commercial entry to Canada. Most recently, Mike co-founded Novescend (Accelera MedTech Canada Inc.) to provide consultation, in-licensing and distribution to US/EU based medical device innovators.


Prior to his role at Accelera Canada, Mike led organizations with interests in the Orphan and Rare disease market segments. As the General Manager and President of PTC Therapeutics Canada and InterMune Canada Inc., he ensured the delivery of tremendous support to patients and caregivers. These companies drove exceptional results in terms of optimal access for patients in need and financial success.

Mike has held positions in Latin America and Europe, serving as Senior Director, Operations, Latin America/Canada and as the Vice-President, Human Resources – Global Marketing for AstraZeneca Inc.
Mike has been responsible for Life Cycle Management in a number of his senior leadership roles. In Canada, as both a senior marketing leader and as the CEO of a number of companies, he has been responsible to develop the strategy and to ensure excellence in the tactical implementation of plans for products in early, mid and late stages of their life cycle. He has engaged in many significant therapeutic classes including Oncology, Neuro-muscular, Cardiology, Gastroenterology, Infectious Disease and Inflammation. Mike has also provided leadership on a global scale in the US, Europe and Latin America.

His leadership in Operations and Global Marketing provided Mike with the opportunity to set clear direction in determining the breadth and depth of product portfolios at Searle and AstraZeneca.

Mike is active on a strategic level sitting and leading a variety of Boards. He chairs the Board of Directors at Arylide Canada, sits on the Boards of OBIO and Alimentiv. He has previously Chaired the Board of Directors at Scientus, Merus Labs International and was a Board Director at Joule, a subsidiary of the Canadian Medical Association. As a result, Mike has an extensive network throughout Canada, the US and International circles.

Mike is a respected, dedicated philanthropist and has served on numerous Boards as a volunteer including the Canadian Stroke Network, Sheridan College Institute of Technology and Advanced Learning and the Canadian Orthopaedic Foundation. Mike is the past Fundraising Chair of the Hazel McCallion Academic Learning Centre at the University of Toronto Mississauga.


Among his many accomplishments, Mike was inducted to the Sheridan College School of Business Marketing Hall of Fame and the Canadian Pharmaceutical Marketing Hall of Fame.


I am energized by this role on the Board as it creates an opportunity for me to contribute my experience, my business acumen and to engage my network with the goal of creating ongoing success for this formidable organization.

View Profile
Ross Feldman


Dr. Ross Feldman is Medical Director, Cardiac Sciences Program for the Winnipeg Regional Health Authority, in addition he is also Professor of Medicine at the University of Manitoba.

He was just recently the Chair of Medicine at Memorial University of Newfoundland, St. John’s Newfoundland & Labrador, Canada. He is the author of more than 200 original manuscripts, reviews and book chapters. His clinical research program centers on the development of new approaches to the management of hypertension and specifically the development of innovative strategies to improve blood pressure control.

A major focus of his efforts has been in the prevention and control of hypertension in Canada and specifically in the knowledge translation of optimal treatment approaches for hypertension management. Among past leadership positions, Dr. Feldman served as the first Chair of the Steering Committee of the Canadian Hypertension Education Program, the organization that since 1999 has produced, disseminated and implemented annually updated guidelines for management of hypertension. As well, he served as President of the Canadian Hypertension Society. He was also the founding President of Hypertension Canada- leading the process of integrating the efforts of the Canadian Hypertension Society, Canadian Hypertension Education Program and Blood Pressure Canada.

He has received a number of awards and scholarships in recognition of his contributions in research, teaching and for his efforts in the prevention and control of hypertension in Canada. These include the George Morris Piersol Research and Teaching Scholarship from the American College of Physicians, a Career Investigator Award from the Heart and Stroke Foundation of Ontario, the Burroughs-Wellcome Clinical Pharmacology Award and the Senior Investigator Award from the Canadian Society for Clinical Pharmacology as well as the Distinguished Service/Research Award of the Canadian Hypertension Society. He also the recipient of the George Fodor Award from Hypertension Canada for outstanding contributions to the prevention and control of hypertension.

View Profile
F. John Mills


Dr. Mills co-founded BioStorage Technologies Inc. (BST) in 2002, recognizing the need for the biopharmaceutical industry to store and manage samples for future biomarker and target identification as well as for analyses performed to meet regulatory requirements. He grew BST through angel and series A funding to a global company that was acquired by Brooks Automation in December 2015.

Since that time, he has been Chairman of DGP Intelsius Ltd., a UK headquartered company specializing in global cold chain packaging solutions. He also serves on the boards of, a pioneer in healthcare relationship management and Diversigen Inc., an early stage Company at Baylor College of Medicine. He has also been a director of IBT Labs and Chantest, both of which were acquired in successful transactions. Before founding BST, Dr. Mills served for four years as corporate senior vice president and president of clinical support services for Covance, Inc., a leading contract research organization headquartered in Princeton, New Jersey. While there, he was responsible for a clinical services division that employed more than 2,000 staff globally. From 1991 to 1998 he was corporate vice president and president of Covance’s clinical business in Europe, operating in 14 countries.

Prior to 1991, Dr. Mills held senior positions for Johnson and Johnson’s pharmaceutical division in Asia (based in Singapore) and the U.K. From 1976 to 1982 he served in the Royal Air Force as a specialist in Aviation Medicine at Farnborough, UK. Dr. Mills received his MD from Cambridge University and his PhD in endocrinology from Surrey University in the United Kingdom. He holds diplomas in pharmaceutical medicine, aviation medicine and marketing and has authored more than 40 scientific papers as well as a textbook on aviation medicine.

View Profile
Joy Nassif


Joy M. Nassif has over 25 years of experience in financial and executive management in the healthcare, diagnostic testing, and pharmaceutical industries. She has a strong record of building and leading global, cross-functional teams while maximizing return on investment through working capital and expense management and customer focus.

Ms. Nassif is currently the Vice President & General Manager, Services for Orasure Technologies. Prior to joining Orasure, Joy was the Chief Operating Officer & Chief Financial Officer of Diversigen, Inc., a microbiome services company. She led the company from start-up to a leader in the microbiome services field. Diversigen was acquired by Orasure in November 2019.

Prior to joining Diversigen, Joy held leadership positions at Quest Diagnostics as Vice President of Clinical Trials, and Vice President of Anatomic Pathology. She held the positions of Chief Financial Officer and Chief Operating Officer of Franklin Heath, Inc. (A Corning Company) and was responsible for all aspects of operations and administration for this start-up healthcare company. Additionally, Joy was Director of Finance for Covance, Inc. working in its Phase II-III contract research organization.

Joy graduated summa cum laude from Kean University with a BS in Accounting. She is a Certified Public Accountant (CPA). In addition to her corporate positions, she has served on the Board of Advisors for several non-profit groups and organizations.

View Profile
Jennifer Roedding

MAcc, CA

Jennifer is an accomplished and innovative business transformation consultant and executive leader with over 20 years of experience adding value and delivering exceptional results to clients.

Jennifer’s experience spans a wide range of clients: from start ups to publicly traded companies. She has worked across many industries including health and life sciences, technology and telecommunications, finance/private equity, public sector, loyalty/call centres and energy. She has assisted organizations with transforming their business processes, change management, governance and organizational realignment, costing and cost modeling, cost optimization and efficiency, as well as mergers/acquisitions/integrations/separations. She has international experience with clients and service delivery teams.

Jennifer graduated from the University of Waterloo with a Master of Accounting degree with a management specialization. Her Master’s thesis was in the area of health case costing and was governmentally funded. Jennifer is certified in Lean Fundamentals through Cardiff University. She is a CA/CPA. Jennifer is currently President of Roedding Associates Management Consultants. Prior to that, she was a Partner in KPMG’s Management Consulting practice.

View Profile
Jürgen Schölmerich


Prof. Schölmerich studied in Freiburg and Heidelberg. His further qualification in Internal Medicine and Gastroenterology was obtained in Freiburg. He was also a research fellow at the University of California at San Diego.

From 1991 until 2010 he was Director of the Department for Internal Medicine I at the University of Regensburg. He was vice president of the German Research Foundation (DFG) from 2005 until 2011 and president of the “German Association of Internal Medicine” (DGIM) 2009-2010. From 2010 until 2016 he was Medical Director and CEO of the Hospital of Johann Wolfgang Goethe University Frankfurt.

His research interests were: inflammatory bowel disease, complications of Liver cirrhosis and bile acid metabolism and effects.

He has published 93 monographs and chapters in teaching and reference books, he is editor or coeditor of 50 books, and his citations exceed 18,000.

View Profile
Cecil Shewchuk

BEndSc, PhD

Dr. Cecil Shewchuk, Principal of Shewchuk Consulting, provides consulting services to technology companies in the areas of business planning, technology and product development, sales and marketing strategy, and implementation roll-out. Many of these consulting engagements have been for international companies specializing in the energy sector.

Dr. Shewchuk has held various executive level positions with large technology companies like Aspen Technology and Honeywell where he was responsible for the strategic planning of sophisticated software products and services in such areas as process simulation, optimization, data analytics and advanced process control.

Dr. Shewchuk has been involved with numerous start-up technology companies in the roles of director, founder, manager or mentor. Many of these companies have been successful in growing into viable profitable operations.

Born in Saskatoon, Saskatchewan, he graduated from the University of Saskatchewan with a Bachelor of Engineering Science degree in Chemical Engineering. He earned his doctorate in Chemical Engineering from Cambridge University in England.

View Profile
Amara Siva


Dr. Siva is an operations executive with over 20 years of molecular diagnostic experience including assay development from concept stage to clinical validation. Dr. Siva is currently Vice President, Laboratory Operations at Epic Sciences where she heads clinical testing operations for the CAP/CLIA, translational research, and manufacturing/tech transfer laboratories. Prior to joining Epic Sciences, she held the role of Chief Operating Officer at Discovery Genomics where she was responsible for all aspects of operations for this start-up clinical laboratory. Prior to that, she held leadership positions as Senior Vice President, Operations at Pathnostics, and Vice President, Laboratory Operations at Millennium Health, where she drove cost savings of over $1.5 million and achieved zero CAP inspection deficiencies.

Prior to joining Millennium Health, Dr. Siva headed BioPharma Lab Operations at Genoptix/Novartis, where she led the development, validation, and implementation of esoteric technologies into the CAP/CLIA laboratory and supported over 35 global hematology/oncology clinical trials exceeding $15 million in total contracts. Additionally, Dr. Siva was a technical leader for clinical biomarker discovery at Gen-Probe, Inc. and Alexion Pharmaceuticals, and is an author of thirteen peer-reviewed publications and an issued patent for compositions and methods for detection of small RNAs.

Dr. Siva received her BS in Biochemistry and Cell Biology from UC San Diego and PhD in Biological Chemistry from UCLA. She is an ASQ-certified Six Sigma Green Belt and is certified as a High-complexity Clinical Laboratory Director by the American Board of Bioanalysis.

In addition to her corporate positions, she has served on the Governing and Editorial Boards for the Malki Museum, California’s first museum founded by Native Americans, as well as on the Board of Advisors for other non-profit organizations.

View Profile